In my opinion, the reason why the share price has not responded is because of the reputation that Kriegsman has created for both himself, the company and any other companies he's affiliated with. He's got a reputation as one of the slimiest, if not the slimiest CEO currently in all of bio. It's going to take a lot for people to look beyond this slimeball and trust the science enough to ignore how terrible a person he is. Every piece of news they've issued lately has been ripped apart and critiqued hard on every stock discussion site and social media avenue I follow, and I believe it's all due to Kriegsman. If they had an honest, communicative, trustworthy CEO, we'd probably be close to $8 right now.
I'm hoping that the evening before data release they announce a cc the morning of data release.
I think it's regrouping now. Probably chop around here a bit more then up we go again.
Unless I'm looking at something wrong, on Nasdaq it's showing that they decreased their position significantly 09/30/2014 to 1,197,796 shares held. But this 13G is saying 712,500 shares. Is this total shares or added?
It's frustrating holding this stock knowing that any moves up are going to be sold into and shorted heavily. I understand it's a long term hold, but the lack of interest is disconcerting.
You'll be able to sell higher than $3. ATHX ran to over $4 last year before UC results, which was essentially Pfizers trial. Stroke is 100% owned by ATHX.
Don't listen to Pipelight. He's a disgruntled investor who can't take responsibility for his investment decisions.
Why is he responsible for when you sell? I assume you're a big boy and can make your own decisions...